Management of central nervous system tuberculosis in children: Light and shade

European Review for Medical and Pharmacological Sciences

Volumn 14, Issue 10, 2010, Pages 845-853

  Buonsenso, D ^a   Serranti, D ^a   Valentini, Piero ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Children; Therapy; Tuberculous meningitis

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; LEVOFLOXACIN; PREDNISONE; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; THALIDOMIDE; TUBERCULOSTATIC AGENT; TUMOR NECROSIS FACTOR ALPHA;

ADJUVANT THERAPY; ARTHROPATHY; BLOATING; BRAIN ABSCESS; CENTRAL NERVOUS SYSTEM TUBERCULOSIS; CHILD; CHILDHOOD; COCHRANE LIBRARY; CORTICOSTEROID THERAPY; DISEASE SEVERITY; DRUG ERUPTION; DRUG MEGADOSE; HEPATITIS; HUMAN; INTRACRANIAL TUBERCULOMA; LIVER TOXICITY; MEDLINE; MYCOBACTERIUM TUBERCULOSIS; NAUSEA; NEPHROTOXICITY; OPTIC NEURITIS; OTOTOXICITY; OVERALL SURVIVAL; PERIPHERAL NEUROPATHY; REVIEW; SALVAGE THERAPY; TUBERCULOUS MENINGITIS; VOMITING; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ADRENAL CORTEX HORMONES; ANTITUBERCULAR AGENTS; HUMANS; MAGNETIC RESONANCE IMAGING; RANDOMIZED CONTROLLED TRIALS AS TOPIC; THALIDOMIDE; TUBERCULOSIS, CENTRAL NERVOUS SYSTEM; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79952224416     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. HUMPHRIES MJ, TEOH R, LAU J, GABRIEL M. Factors of prognostic significance in Chinese children with tuberculous meningitis. Tubercle 1990; 71: 161-168.
2. VAN WELL GT, PAES BF, TERWEE CB, SPRINGER P, ROORD JJ, DONALD PR, VAN FURTH AM, SCHOEMAN JF. Twenty years of pediatric tuberculous meningitis: a retrospective cohort study in the western cape of South Africa. Pediatrics 2009; 123: e1-8.
3. PARSONS M. Tuberculous meningitis: A handbook for clinicians. A handbook for clinicians. Oxford: Oxford University Press, 1988: pp. 32-62.
4. ELLARD GA, HUMPHRIES MJ, ALLEN BW. Cerebrospinal fluid drug concentrations and the treatment of tuberculous meningitis. Am Rev Respir Dis 1993;148: 650-655.
5. THWAITES GE, LAN NT, DUNG NH, QUY HT, OANH DT, THOA NT, HIEN NQ, THUC NT, HAI NN, BANG ND, LAN NN, DUC NH, TUAN VN, HIEP CH, CHAU TT, MAI PP, DUNG NT, STEPNIEWSKA K, WHITE NJ, HIEN TT, FARRAR JJ. Effect of antituberculosis drug resistance on response to treatment and outcome in adults with tuberculous meningitis. J Infect Dis 2005; 192: 79-88.
6. ALFFENAAR JW, VAN ALTENA R, BÖKKERINK HJ, LUIJCKX GJ, VAN SOOLINGEN D, AARNOUTSE RE, VAN DER WERF TS. Plasma and CSF pharmacokinetics of moxifloxacin in a patient with tuberculous meningitis. Clin Infect Dis 2009; 49: 1080-1082.
7. VAN LOENHOUT-ROOYACKERS JH, KEYSER A, LAHEIJ RJ, VERBEEK AL, VAN DER MEER JW. Tuberculous meningitis: is a 6-month treatment regimen sufficient? Int J Tuberc Lung Dis 2001; 5: 1028-1035.
8. THE NATIONAL COLLABORATING CENTRE FOR CHRONIC CONDITIONS. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. London: Royal College of Physicians; 2006.
9. TAHAOǦLU K, ATAÇ G, SEVIM T, TÄRÜN T, YAZICIOǦLU O, HORZUM G, GEMCI I, ONGEL A, KAPAKLI N, AKSOY E. The management of anti-tuberculosis drug-induced hepatotoxicity. Int J Tuberc Lung Dis 2001; 5: 65-69.
10. THOMPSON NP, CAPLIN ME, HAMILTON MI, GILLESPIE SH, CLARKE SW, BURROUGHS AK, MCINTYRE N. Anti-tuberculosis medication and the liver: dangers and recommendations in management. Eur Respir J 1995; 8: 1384-1388.
11. GREEN JA, TRAN CT, FARRAR JJ, NGUYEN MT, NGUYEN PH, DINH SX, HO ND, LY CV, TRAN HT, FRIEDLAND JS, THWAITES GE. Dexamethasone, cerebrospinal fluid matrix metalloproteinase concentrations and clinical outcomes in tuberculous meningitis. PLoS ONE 2009; 4: e7277.
12. COYLE PK. Glucocorticoids in Central Nervous System bacterial infection. Arch Neurol 1999; 56:796-801.
13. BROOKS WD, FLETCHER AP, WILSON RR. Spinal cord complications of tuberculous meningitis; a clinical and pathological study. Q J Med 1954; 23: 275-290.
14. GIRGIS NI, FARID Z, KILPATRICK ME, SULTAN Y, MIKHAIL IA. Dexamethasone adjunctive treatment for tuberculous meningitis. Pediatr Infect Dis J 1991; 10: 179-183.
15. GIRGIS NI, SULTAN Y, FARID Z, MANSOUR MM, ERIAN MW, HANNA LS, MATECZUN AJ. Tuberculosis meningitis, Abbassia Fever Hospital-Naval Medical Research Unit No. 3-Cairo, Egypt, from 1976 to 1996. Am J Trop Med Hyg 1998; 58: 28-34.
16. KUMARVELU S, PRASAD K, KHOSLA A, BEHARI M, AHUJA GK. Randomized controlled trial of dexamethasone in tuberculous meningitis. Tuber Lung Dis 1994; 75: 203-207.
17. SCHOEMAN JF, VAN ZYL LE, LAUBSCHER JA, DONALD PR. Effect of corticosteroids on intracranial pressure, computed tomographic findings, and clinical outcome in young children with tuberculous meningitis. Pediatrics 1997; 99: 226-231.
18. THWAITES GE, NGUYEN DB, NGUYEN HD, HOANG TQ, DO TT, NGUYEN TC, NGUYEN QH, NGUYEN TT, NGUYEN NH, NGUYEN TN, NGUYEN NL, NGUYEN HD, VU NT, CAO HH,TRAN TH, PHAM PM, NGUYEN TD, STEPNIEWSKA K, WHITE NJ, TRAN TH, FARRAR JJ. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med 2004; 351: 1741-1751.
19. PRASAD K, VOLMINK J, MENON GR. Steroids for treating tuberculous meningitis. Cochrane Database Syst Rev 2000; (3): CD002244.
20. PRASAD K, SINGH MB. Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev 2008; (1): CD002244.
21. EVANS DJ. The use of adjunctive corticosteroids in the treatment of pericardial, pleural and meningeal tuberculosis: do they improve outcome? Respir Med 2008; 102:793-800.
22. FU LM, FU-LIU CS. Thalidomide and tuberculosis. Int J Tuberc Lung Dis 2002; 6: 569-572.
23. SAMPAIO EP, KAPLAN G, MIRANDA A, NERY JA, MIGUEL CP, VIANA SM, SARNO EN. The influence of thalidomide on the clinical and immunological manifestation of erythema nodosum leprosum. J Infect Dis 1993; 168: 408-414.
24. MOREIRA AL, TSENOVA-BERKOVA L, WANG J, LAOCHUMROONVORAPONG P, FREEMAN S, FREEDMAN VH, KAPLAN G. Effect of cytokine modulation by thalidomide on the granulomatous response in murine tuberculosis. Tuber Lung Dis 1997; 78: 47-55.
25. TSENOVA L, SOKOL K, FREEDMAN VH, KAPLAN G. A combination of thalidomide plus antibiotics protects rabbits from mycobacterial meningitis-associated death. J Infect Dis 1998; 177: 1563-1572.
26. TSENOVA L, BERGTOLD A, FREEDMAN VH, YOUNG RA, KAPLAN G. Tumor necrosis factor a is a determinant of pathogenesis and disease progression in mycobacterial infection in the central nervous system. Proc Natl Acad Sci 1999; 96: 5657-5662.
27. TSENOVA L, MANGALISO B, MULLER G, CHEN Y, FREEDMAN VH, STIRLING D, KAPLAN G. Use of IMiD3, a thalidomide analog, as an adjunct to therapy for experimental tuberculous meningitis. Antimicrob Agents Chemother 2002; 46: 1887-1895.
28. SCHOEMAN JF, SPRINGER P, RAVENSCROFT A, DONALD PR, BEKKER LG, VAN RENSBURG AJ, HANEKOM WA, HASLETT PA, KAPLAN G. Adjunctive thalidomide therapy of childhood tuberculous meningitis: possible anti-inflammatory role. Child Neurol 2000; 15: 497-503.
29. SCHOEMAN JF, RAVENSCROFT A, HARTZENBERG HB. Possible role of adjunctive thalidomide therapy in the resolution of a massive intracranial tuberculous abscess Child's Nerv Syst 2001; 17: 370-372.
30. ROBERTSA MTM, MENDELSONA M, MEYERB P, CARMICHAELA A, LEVERA AML. The use of thalidomide in the treatment of intracranial tuberculomas in adults: two case reports. J Infect 2003; 47: 251-255.
31. SCHOEMAN JF, SPRINGER P, VAN RENSBURG AJ, SWANEVELDER S, HANEKOM WA, HASLETT PA, KAPLAN G. Adjunctive thalidomide therapy for childhood tuberculous meningitis: results of a randomized study. J Child Neurol 2004; 19: 250-257.
32. SCHOEMAN JF, FIEGGEN G, SELLER N, MENDELSON M, HARTZENBERG B. Intractable intracranial tuberculous infection responsive to thalidomide: report of four cases. J Child Neurol 2006; 21: 301-308.
33. STEFAN DC, ANDRONIKOU S, FREEMAN N, SCHOEMAN J. Recovery of vision after adjuvant thalidomide in a child with tuberculous meningitis and acute lymphoblastic leukemia. J Child Neurol 2009; 24: 166-169.
34. BEKKER LG, HASLETT P, MAARTENS G, STEYN L, KAPLAN G. Thalidomide-induced antigen-specific immune stimulation in patients with human immunodeficiency virus type 1 and tuberculosis. J Infect Dis 2000; 181: 954-965.
35. COULTER JB, BARETTO RL, MALLUCCI CL, ROMANO MI, ABERNETHY LJ, ISHERWOOD DM, KUMARARATNE DS, LAMMAS DA. Tuberculous meningitis: protracted course and clinical response to interferon-gamma. Lancet Infect Dis 2007; 7: 225-232.
36. THWAITES G, FISHER M, HEMINGWAY C, SCOTT G, SOLOMON T, INNES J; BRITISH INFECTION SOCIETY. British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children. J Infect 2009; 59: 167-187.